13G Filing: Armistice Capital and Biopharmx Corp (BPMX)

Page 5 of 11

Page 5 of 11 – SEC Filing

CUSIP No 09072X101
Item 1. (a). Name of Issuer:
BioPharmX Corporation
(b). Address of Issuer’s Principal Executive Offices:

1505 Adams Drive, Suite D

Menlo Park, California 94025

United States of America

Item 2. (a). Name of Person Filing:

Armistice Capital, LLC

Armistice Capital Master Fund Ltd.

Steven Boyd

(b). Address of Principal Business Office, or if None, Residence:

Armistice Capital, LLC

510 Madison Avenue, 22nd Floor

New York, New York 10022

United States of America

Armistice Capital Master Fund Ltd.

c/o dms Corporate Services Ltd.

20 Genesis Close

P.O. Box 314

Grand Cayman KY1-1104

Cayman Islands

Steven Boyd

c/o Armistice Capital, LLC

510 Madison Avenue, 22nd Floor

New York, New York 10022

United States of America

(c) Citizenship:

Armistice Capital, LLC – Delaware

Armistice Capital Master Fund Ltd. – Cayman Islands

Steven Boyd – United States of America

(d).   Title of Class of Securities:
Common Stock, $0.001 par value
(e). CUSIP Number:
09072X101

Follow Timber Pharmaceuticals Inc. (NYSE:TMBR)

Page 5 of 11